You are viewing the site in preview mode

Skip to main content

Table 2 Comparison of RELN expression levels in controls, and SCZ patients before and after treatment (2−ΔΔCt)

From: Exploring the mRNA expression level of RELN in peripheral blood of schizophrenia patients before and after antipsychotic treatment

  RELN P
Total
Control (48) 1.25 ± 0.13  
SCZ (30) 0.86 ± 0.09 0.0476 a
SCZ_12W (30) 1.32 ± 0.15 0.0384 b
Female
Control (31) 1.20 ± 0.14  
SCZ (16) 0.64 ± 0.07 0.0025 a
SCZ_12W (16) 1.33 ± 0.24 0.0507 b
Male
Control (17) 1.35 ± 0.28  
SCZ (14) 1.10 ± 0.16 0.9844 a
SCZ_12W (14) 1.32 ± 0.17 0.3575 b
  1. Abbreviations: Control Healthy control, SCZ Untreated schizophrenia patients, SCZ_12w Schizophrenia patients after 12 weeks of antipsychotic treatment; a: comparisons between the untreated schizophrenia patients and healthy control (Mann-Whitney U test); b: comparisons between the schizophrenia patients after 12 weeks of antipsychotic treatment and untreated schizophrenia patients (paired Wilcoxon signed-rank test); Bold figures indicate P < 0.05
\